|
| 37260198 | Smoking habit change after cancer diagnosis: effect on cardiovascular risk. | Eur Heart J | 2024 |
| 37758044 | Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. | Am Heart J | 2024 |
| 37632469 | Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests. | Circulation | 2024 |
| 37956961 | Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. | J Am Coll Cardiol | 2024 |
| 38000444 | Promise of a Novel Classification System for Acute Myocardial Infarction. | Can J Cardiol | 2024 |
| 37999662 | SGLT2 Inhibitors in Patients With Cancer Therapy-Related Cardiotoxicity: An Unexpected Benefit? | JACC Heart Fail | 2024 |
| 38057157 | Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome. | Eur J Prev Cardiol | 2024 |
| 37889071 | Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use. | Eur Heart J | 2024 |
| 37495798 | Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trials. | Clin Res Cardiol | 2024 |
| 38092897 | Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trial. | Nat Med | 2024 |
| 37768249 | 1+2 Might Be >2: SGLT Inhibition in Patients With Heart Failure or Chronic Kidney Disease. | JACC Heart Fail | 2024 |
| 35821087 | Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: An individual patient data pooled meta-analysis of randomized trials. | J Thorac Cardiovasc Surg | 2024 |
| 37421436 | GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromes. | Clin Res Cardiol | 2024 |
| 34761666 | Dual pathway inhibition in atherothrombosis prevention: yes, now we can! | Minerva Cardiol Angiol | 2023 |
| 37758440 | Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2023 |
| 37804290 | 1- or 3-Month DAPT in Patients With HBRÂ With or Without Oral Anticoagulant Therapy After PCI. | JACC Cardiovasc Interv | 2023 |
| 37632738 | Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry. | Eur Heart J | 2023 |
| 37961715 | An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized controlled trials. | medRxiv | 2023 |
| 37914514 | Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c. | J Am Coll Cardiol | 2023 |
| 37558385 | Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF. | JACC Heart Fail | 2023 |
| 37556796 | Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes. | Diabetes Care | 2023 |
| 37660719 | Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. | Lancet | 2023 |
| 37622416 | Baseline characteristics of patients enrolled in the EMPACT-MI trial. | Eur J Heart Fail | 2023 |
| 38001154 | An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials. | NPJ Digit Med | 2023 |
| 37847791 | Changes in physical activity and incident cardiovascular events in cancer survivors. | Eur Heart J | 2023 |
| 37790598 | Pre-arterialization of coronary veins prior to retroperfusion of ischemic myocardium: percutaneous closure device. | Front Cardiovasc Med | 2023 |
| 37702079 | Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5â¿¿Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial. | J Am Heart Assoc | 2023 |
| 37996192 | Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial. | Lancet Diabetes Endocrinol | 2023 |
| 37698294 | Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation. | Catheter Cardiovasc Interv | 2023 |
| 37995152 | Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention. | J Am Coll Cardiol | 2023 |
| 37993206 | Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week. | J Am Coll Cardiol | 2023 |
| 37942641 | Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry. | Stroke | 2023 |
| 37609850 | Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. | Circ Cardiovasc Interv | 2023 |
| 37690915 | Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review. | Clin Ther | 2023 |
| 37542095 | Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study. | Sci Rep | 2023 |
| 37879802 | Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions. | JACC Cardiovasc Interv | 2023 |
| 37685628 | Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions. | J Clin Med | 2023 |
| 37731004 | Higher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic Stroke. | Ann Neurol | 2023 |
| 37730292 | Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2023 |
| 37641636 | Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population. | Eur Heart J Open | 2023 |
| 37494987 | Regression and stabilization of atherogenic plaques. | Trends Cardiovasc Med | 2023 |
| 37494865 | Successful Endovascular Treatment of an Anastomotic Pseudoaneurysm in the Ascending Aorta. | Am J Cardiol | 2023 |
| 38030354 | Reporting Extended Follow-Up in Cardiovascular Clinical Trials. | J Am Coll Cardiol | 2023 |
| 37969642 | Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review. | JACC CardioOncol | 2023 |
| 37674356 | Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. | Eur Heart J | 2023 |
| 35638241 | The relationship between mortality and daily number of steps in type 2 diabetes. | Panminerva Med | 2023 |
| 37219553 | Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation. | JAMA | 2023 |
| 37087166 | Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply. | Lancet | 2023 |
| 37456347 | Outcomes of Prediabetes Compared with Normoglycaemia and Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. | Heart Int | 2023 |
| 37455788 | Development and validation of a predictive model for the diagnosis of rheumatic heart disease in low-income countries based on two cross-sectional studies. | Int J Cardiol Cardiovasc Risk Prev | 2023 |